Fat Injections for Weight Loss: What the Term Really Means

Step 1: Understanding what "fat injections" are (and aren't)

When patients and search engines use the term "fat injections for weight loss", they're almost never describing an injection of fat into the body, that's a cosmetic procedure with a completely different purpose. What they mean, almost universally, is the subcutaneous (under the skin) injection of a gut-hormone medicine designed to reduce appetite and slow the passage of food through the stomach.

The two medicines that fit this description in the UK are tirzepatide, sold as Mounjaro and made by Eli Lilly, and semaglutide, sold as Wegovy and made by Novo Nordisk. Tirzepatide is unique in activating two gut-hormone receptors simultaneously (GIP and GLP-1) making it the only dual-agonist weight-loss medicine currently licensed in the UK. Semaglutide targets the GLP-1 receptor alone. Both slow gastric emptying and signal fullness to the brain, which naturally leads most people to eat less without conscious effort. The NHS medicines page for tirzepatide explains this mechanism clearly if you'd like the detail straight from a Tier-1 clinical source.

Neither medicine dissolves or breaks down fat directly. The weight loss comes from a sustained calorie deficit created by reduced appetite, not from a chemical acting on fat cells. That distinction matters when you're reading marketing language online, and a question our prescribers hear most weeks is exactly this: "do these injections burn fat, or just suppress hunger?" The honest answer is more nuanced than either option, and worth reading properly.

Step 2: The injection process, where it goes and how it's given

"Subcutaneous" means just beneath the skin, not into muscle and not into a fat deposit being targeted for removal. You inject into a pinched fold of skin, typically on the abdomen, outer thigh, or upper arm, rotating the site weekly to avoid localised irritation. The pre-filled pen does most of the work, there's no drawing up of liquid and no dialling of a dose in the traditional sense. Each Mounjaro KwikPen contains four weekly doses; each Wegovy pen is single-use.

The site you choose doesn't determine where your body loses weight. That's governed by your metabolism, genetics and how long you've been on treatment, not by where the pen touches your skin. If you've seen claims that injecting into a particular spot targets belly fat specifically, that's not how these medicines work. There's a fuller breakdown of how weight-loss injections interact with abdominal fat if that's your main concern.

For the injection itself, clean the skin first, let the area settle, and follow the technique in your Patient Information Leaflet exactly. Swapping needles after each dose and storing your pen correctly (refrigerated between 2°C and 8°C; the leaflet gives the precise room-temperature window) keeps everything sterile and the medicine stable.

Step 3: Dose titration, why it starts lower than the treatment dose

Both medicines begin at a starter dose that exists primarily to settle the digestive system, not to produce meaningful weight loss. For tirzepatide, that's 2.5mg for the first four weeks. For semaglutide (Wegovy), it's 0.25mg. These early doses are deliberately low, nausea, bloating and loose stools are common as the body adjusts, and starting gently reduces how severe and prolonged those effects tend to be.

From there, a prescriber steps the dose up in stages, typically every four weeks, until you reach the highest dose your body tolerates. Tirzepatide's licensed range runs to 15mg; Wegovy's standard maintenance dose is 2.4mg, with a higher 7.2mg option now also approved by the MHRA for eligible patients. The titration schedule is never something to alter without clinical input, jumping ahead to feel results faster usually means worse side effects and sometimes a step back down. Our overview of weight-loss injections covers the schedule and what to expect at each stage.

NICE's appraisal of tirzepatide (TA1026, published December 2024) assessed the clinical evidence across the SURMOUNT trial programme, which involved thousands of adults with obesity. At the 15mg dose over 72 weeks, average body-weight reduction was around 20–21%. That figure comes from a controlled trial setting; real-world results vary, and no medicine produces identical outcomes for every person.

Step 4: Eligibility, safety and getting started the right way

Both tirzepatide and semaglutide are prescription-only medicines. The licensed criteria for private prescribing are: adults with a BMI of 30 or above, or a BMI of 27 or above alongside a weight-related condition such as high blood pressure, high cholesterol, prediabetes, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. Meeting those numbers is a starting point, not an automatic green light, a prescriber also considers your medical history, current medicines and any contraindications before approving treatment.

Common side effects are largely gastrointestinal: nausea, loose stools, constipation, reflux, and occasional burping or fatigue, especially in the early weeks and after dose increases. These usually settle. Acute pancreatitis is a rarer but serious risk; get urgent help for severe stomach pain that radiates to the back. The MHRA issued a specific Drug Safety Update on pancreatitis and GLP-1 medicines in January 2026, reporting side effects through the Yellow Card scheme helps the regulator track patterns across the whole population.

One practical note: if you've been searching for these injections online and seen prices far below the market rate, that's worth pausing on. The MHRA has confirmed that counterfeit weight-loss pens, some containing insulin rather than the labelled medicine, have been seized in large volumes across the UK and have caused hospitalisations. The only safe route is a prescription from a registered prescriber, dispensed by a pharmacy you can verify on the GPhC register. Details on where to buy weight-loss injections safely are worth reading before you commit to any provider.

If you'd like to understand whether you meet the criteria and which medicine a prescriber might consider for your situation, you can explore the weight thresholds and conditions that inform that assessment, or take a look at our free consultation to speak with a GPhC-registered prescriber directly. There's no obligation, and the clinical review is handled the same day. If Mounjaro is the medicine you're considering, you can also read more about the Mounjaro injection for weight loss and how it compares to other options.